Mammalian Transient Protein Expression Market
Number of pages: 100 | Report Format: PDF | Published date: May 08, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023 to 2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 642.12 million |
|
Revenue Forecast in 2031 |
US$ 1,280.94 million |
|
CAGR |
7.9% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product, Application, End user, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global mammalian transient protein expression market was valued at US$ 642.12 million in 2022 and is expected to register a revenue CAGR of 7.9% to reach US$ 1,280.94 million by 2031.
Mammalian Transient Protein Expression Market Fundamentals
Mammalian cells have a particular class of transient protein called mammalian transient protein, which is only present for a brief duration. It is used in several procedures, including DNA replication, cell division, and protein synthesis, that are essential for the survival and operation of the cell. They are also crucial in the process of apoptosis, which is how cells pass away when they are no longer required.
The global mammalian transient protein expression industry analysis report comprehensively analyzes the market, with factors that either aid or impede the market growth, such as its drivers, restraints, and opportunities. The research provides insight into the companies that operate in the mammalian transient protein expression market and their efforts to position themselves as key players through expansion strategies and innovations. It also highlights recent developments that contribute to the mammalian transient protein expression market growth. The research also analyzes the impact of the COVID-19 pandemic.
This research is valuable for businesses seeking insights into the market, customers, and competition. The research provides special insights into the segmentation, regions, market size & projection, revenue CAGRs, and other valuable information that may help clients make the right decisions. The report assembles data from market players and professionals across the industrial value chain. The study also incorporates qualitative and quantitative assessments from industry professionals. Secondary research, surveys and interviews, and statistical modeling are all used in our research to estimate market size and projection. Our reports deliver the most reliable market data because of our specialized research methods.
[1254]
Mammalian Transient Protein Expression Market Dynamics
In recent years, the global mammalian transient protein expression market has experienced rapid growth. The global mammalian transient protein expression market is also growing, fueled by increased industry research and development efforts and advancements in technology and methods that enable more precise and effective protein production. The increased need for pharmaceuticals and other treatments boosts the mammalian transient protein expression industry. The development of innovative delivery techniques, such as nanotechnology and drug-delivery products, facilitates the utilization of mammalian cells for protein expression as therapeutic agents. It is anticipated to fuel market growth for this product in the future. The pharmaceutical and biomedical sectors, which require enormous quantities of high-quality transient proteins for their research and development, have been the major industries that have driven the growth of the global mammalian transient protein market.
Mammalian Transient Protein Expression Market Ecosystem
Mammalian Transient Protein Expression Market, by Product
Mammalian Transient Protein Expression Market, by Application
Mammalian Transient Protein Expression Market, by End User
Mammalian Transient Protein Expression Market by End User
[2365]
The biopharmaceutical companies segment accounts for the largest revenue share in the global mammalian transient protein expression market. Mammalian cells are the preferred choice to produce biopharmaceuticals, as they offer several advantages, including the ability to produce complex proteins with post-translational modifications, high yields, and scalability. Transient protein expression systems are preferred over stable expression systems to produce biopharmaceuticals during the initial stages of drug development, as they offer faster production times and lower costs. Additionally, transient expression systems allow researchers to assess multiple protein variants and optimize protein expression conditions before moving on to stable expression systems.
The market segmentation sections provide the mammalian transient protein expression market outlook in terms of the demarcation of different consumer groups. Market segmentation is the split of industry into subgroups depending on characteristics such as product, application, end user, and region. Market segmentation data helps organizations understand the preferences and distinctive demands of different customer groups and implement targeted marketing strategies. This data additionally helps in identifying potential mammalian transient protein expression market demand opportunities.
Mammalian Transient Protein Expression Market by Region
North America accounts for a significant share of the global mammalian transient protein expression market. This is due to the presence of several leading biotechnology and pharmaceutical companies in the region, as well as an advanced healthcare infrastructure. The United States is the largest market for mammalian transient protein expression in North America. The market is driven by the increasing demand for biologics, such as monoclonal antibodies, vaccines, and recombinant proteins, for therapeutic and research purposes. Mammalian cells are preferred for protein expression because they can produce complex proteins with post-translational modifications like those found in humans. Additionally, transient expression systems are preferred over stable expression systems for early-stage research, as they offer rapid protein expression and cost-effective production.
The Asia Pacific region is expected to witness significant growth in the mammalian transient protein expression market due to the growing biopharmaceutical industry in the region. The rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases has increased the demand for biopharmaceuticals in the region. Additionally, the increasing investments in research and development activities by pharmaceutical and biotechnology companies, coupled with the favorable regulatory environment, are driving the market growth in the region.
Based on the regions, the global mammalian transient protein expression market is segmented into:
The industry's regional segmentation provides insights into geographic pockets in terms of mammalian transient protein expression industry trends, market size, share, and growth rate. This information helps organizations assess potential growth opportunities in new regional markets, understand competitive threats, and develop localized sales and expansion strategies. This section also offers deeper insights into the regional and country-level mammalian transient protein expression market overview.
Key Components of the Report
Mammalian Transient Protein Expression Market Competitive Landscape
The market competitive landscape analysis is performed by gathering and evaluating data about the key competitors, industry trends, and market dynamics. It involves collecting and analyzing data on factors such as products, pricing, geographic reach, customer demographics, marketing tactics, and recent developments. Competitive landscape analysis can help organizations identify present or prospective opportunities and risks in the market.
Mammalian Transient Protein Expression Market Strategic Developments
Reasons To Buy This Report
Key Strengths of Our Report
Target Audience to Benefit from this Report.
Mammalian transient protein expression temporarily creates proteins in mammalian cells, usually for a few days to a few weeks. This method entails utilizing a transfection technique, such as electroporation or lipid-mediated transfection, to introduce a DNA sequence encoding the protein of interest into mammalian cells. The DNA sequence is translated into messenger RNA (mRNA) once it has entered the cells, and the cellular machinery then translates mRNA into protein.
The global mammalian transient protein expression market was valued at US$ 642.12 million in 2022.
The Asia Pacific region is likely to register a high revenue CAGR of the mammalian transient protein expression market during the forecast period.
The global mammalian transient protein expression is expected to grow at 7.9% revenue CAGR during the forecast period from 2023 to 2031.
The resultant market size of the mammalian transient protein expression market is expected to reach US$ 1,280.94 million by 2031.
The widespread use of gene editing techniques like CRISPR/Cas9 to enhance protein expression is one of the most obvious trends in the mammalian transient protein expression market.
Merck KGaA, Promega Corporation, Lonza Group AG, Agilent Technologies, Inc., and Thermo Fisher Scientific Corporation are a few key players in the global mammalian transient protein expression market.
Mammalian transient protein expression is often associated with high production costs due to the need for specialized equipment, cell lines, and reagents. This can limit its use for large-scale protein production.
The biopharmaceutical companies segment accounts for the highest revenue share in the global mammalian transient protein expression market.
*Insights on financial performance are subject to the availability of information in the public domain